Flow cytometry shows a reduction of ILC3 (CD45+IL-22+RORγt+) in both intestinal and blood samples in PCOS individuals and PCOS-like animal models; furthermore, it also exhibits a therapeutic role in PCOS [57]. This evidence concerns the gene PTPRC and polycystic ovary syndrome.